Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Cytochrome P450 2B6 (human) polyclonal antibody

 
BML-CR3296-0400 400 µl 375.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:CYP2B6
 
Host:Rabbit
 
Immunogen:KLH-conjugated synthetic peptide corresponding to the internal region of human CYP2B6.
 
UniProt ID:P20813
 
Species reactivity:Human
 
Specificity:Recognizes human CYP2B6, epitope aa 242-270.
 
Applications:IF, IHC (PS), WB
 
Recommended Dilutions/Conditions:Immunofluorescence (1:10-50)
Immunohistochemistry (1:50-100)
Immunohistochemistry (paraffin sections, 1:10-50)
Western Blot (1:1,000)
Suggested dilutions/conditions may not be available for all applications.
Optimal conditions must be determined individually for each application.
 
Purity Detail:Immunoaffinity purified.
 
Formulation:Liquid. In PBS containing 0.09% sodium azide.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:-20°C
 
BML-CR3296 IHC
Immunohistochemistry analysis: formalin fixed and paraffin embedded human hepatocarcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining.
BML-CR3296 ICC
Immunocytochemistry analysis: Confocal immunofluorescence of CYP2B6 Antibody with HEK293 cells followed by Alexa Fluor 488-conjugated goat anti-rabbit lgG (green). DAPI was used to stain the cell nuclear (blue).
BML-CR3296 WB
Western Blot analysis: Western blot of 293 and K562 cell line lysates (35micro;g/lane). This demonstrates the CYP2B6 antibody detected the CYP2B6 protein (arrow).
Please mouse over
BML-CR3296 IHC BML-CR3296 ICC BML-CR3296 WB

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Cytochrome P450
By biological activity:
Cytochrome P450 Polyclonal antibody
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,